Ardian, Sagemount, Eir, Thoma Bravo back life sciences software; 1315 Capital eyes value creation potential in Argonaut’s diagnostics division

AI and regulatory complexity are driving demand for life sciences software, which in turn has attracted private equity; 1315 Capital closes a carve-out deal with a portfolio company of Telegraph Hill Partners and New Vale Capital.

North AmericaUSHealthcareTMTCommentaryPE Hub Wire